Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease

Citation:

d’Angremont E, Begemann MJH, van Laar T, et al. JAMA Neurol. 2023 Aug 1;80(8):813-823. PMID: 37358841; PMCID: PMC10294019.